رجوع
نطاق اليوم
KWD 18.49
KWD 19.43
نطاق 52 أسبوعًا
KWD 17.15
KWD 42.50
حجم التداول
3,140,913
متوسط 50 يوم / 200 يوم
KWD 21.91
/
KWD 27.71
الإغلاق السابق
KWD 19.26
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -10.1 | 0.3 |
| P/B | 9.4 | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -66.3 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.7 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 31.330
+62.8%
Low: KWD 26.000
High: KWD 38.000
مكرر الربحية المستقبلي
109.4
ربحية السهم المستقبلية
KWD 0.176
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.156
KWD 1.139 – KWD 1.180
|
1.8 B | 2 |
| FY2029 |
KWD 1.068
KWD 1.052 – KWD 1.090
|
1.7 B | 4 |
| FY2028 |
KWD 0.707
KWD 0.438 – KWD 0.968
|
1.4 B | 6 |
النقاط الرئيسية
Generating 66.90M in free cash flow
Capital efficient — spends only 2.00% of revenue on capex
ROIC of 3.54% — low return on invested capital
Interest coverage of 0.79× — tight debt servicing
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)96.97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROIC3.54%
Net Margin-66.25%
Op. Margin5.56%
الأمان
Debt / Equity
0.66
Current Ratio7.85
Interest Coverage0.79
التقييم
P/E Ratio
-10.11
P/B Ratio9.42
EV/EBITDA111.23
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 96.97% | Revenue Growth (3Y) | 62.87% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 812.03M | Net Income (TTM) | -537.96M |
| ROE | N/A | ROA | -47.79% |
| Gross Margin | 66.40% | Operating Margin | 5.56% |
| Net Margin | -66.25% | Free Cash Flow (TTM) | 66.90M |
| ROIC | 3.54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.66 | Current Ratio | 7.85 |
| Interest Coverage | 0.79 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.11 | P/B Ratio | 9.42 |
| P/S Ratio | 6.70 | PEG Ratio | 2.83 |
| EV/EBITDA | 111.23 | Dividend Yield | 0.00% |
| Market Cap | 5.44B | Enterprise Value | 5.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 812.03M | 412.26M | 306.13M | 258.49M | 294.01M |
| Net Income | -537.96M | -281.89M | -341.42M | -320.83M | 27.73M |
| EPS (Diluted) | -1.90 | -2.70 | -1.82 | -1.57 | 1.55 |
| Gross Profit | 539.17M | 178.78M | 89.31M | 80.02M | 184.16M |
| Operating Income | 45.11M | -257.12M | -319.55M | -315.76M | 139.09M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1.13B | 343.73M | 412.90M | 717.42M | 2.61B |
| Total Liabilities | 548.36M | 2.84B | 2.56B | 2.42B | 1.91B |
| Shareholders' Equity | 577.31M | -2.50B | -2.14B | -1.70B | 702.24M |
| Total Debt | 378.99M | 424.26M | 217.27M | 270.87M | 1.75B |
| Cash & Equivalents | 797.80M | 63.95M | 56.40M | 107.19M | 53.55M |
| Current Assets | 997.80M | 215.73M | 242.61M | 516.04M | 214.66M |
| Current Liabilities | 127.15M | 165.42M | 95.14M | 136.91M | 320.25M |